Refer A Patient

Request An Appointment

Neurology

Kisunla

Kisunla (donanemab-azbt) treatment for early symptomatic Alzheimer’s Disease, which includes mild cognitive impairment (MCI) or mild dementia stage of disease.
Infusion or injection therapy referral
What it treats Early symptomatic Alzheimer's disease
Prescribed by Neurologists
How it’s administered Intravenous (IV) infusion
Frequency Every 4 weeks
Length of treatment 18 months

About This Therapy

Kisunla (donanemab-azbt) treatment for early symptomatic Alzheimer’s Disease, which includes mild cognitive impairment (MCI) or mild dementia stage of disease.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

KISUNLA REFERRAL FORM

Kisunla REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for Kisunla

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.